FindMyKOL
Clinical trialNCT02994355CompletedInterventional

HIV Testing at Family Planning Clinics in Mombasa County, Kenya

SponsorUniversity of WashingtonEnrollment24HIV
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Location: Family Planning Clinics in Mombasa County, Kenya Introduction: Integration of HIV treatment and prevention with family planning (FP) services is a promising approach for optimizing delivery of comprehensive healthcare for HIV-positive women, as well as prevention services for those who are negative. In Mombasa County, the USAID-supported AIDS Population and Health Integrated Assistance II Program revised the FP Clinic Register to capture HIV testing in 2008. However, the rate of HIV testing in FP clinics remains low. Our overarching objective is to assess the effectiveness, costs, and budget impact of implementing the systems analysis and improvement approach (SAIA) to increase HIV testing in FP clinics in Mombasa County. Methods: The investigators aim to conduct a cluster-randomized trial comparing the effect of the SAIA approach versus usual procedures on rates of HIV testing in first-time attendees at 20 intervention versus 20 control FP clinics in Mombasa County. The investigators will compare HIV testing rates for first-time FP clinic attendees in SAIA intervention versus control facilities after an additional year, during which FP clinics in the intervention arm will be encouraged to continue to use the SAIA tools with minimal support from the study team as the Mombasa County Ministry of Health will take ownership of implementation. Lastly, the investigators aim to estimate the incremental cost and budget impact of applying SAIA versus standard of care using an activity-based approach. Anticipated Results: The investigators anticipate that SAIA will produce significant and sustained improvement in HIV-testing rates in first-time FP clinic attendees in intervention clinics compared to control facilities. The use of a rigorous study design will provide strong evidence to guide integration of HIV testing into FP services in a wide range of settings. The inclusion of costing and budget impact analyses will assist policy makers in reaching informed decisions about implementation. Anticipated Conclusion: By addressing the crucial first step in the linkage of HIV and FP services, this research holds considerable promise for improving women's health by opening the gateway to HIV care and prevention.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Raymond S McClelland, MD, MPH

    Professor of Medicine, Epidemiology, Global Health

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Kenya
  • Alfarooq

    Mombasa, Kenya

  • Jocham

    Mombasa, Kenya

  • Junda

    Mombasa, Kenya

  • Junda Dispensary

    Mombasa, Kenya

  • Kongowea

    Mombasa, Kenya

  • Magongo

    Mombasa, Kenya

  • Marimani

    Mombasa, Kenya

  • Mbuta

    Mombasa, Kenya

  • Mikindani

    Mombasa, Kenya

  • Mlaleo

    Mombasa, Kenya

  • Mrima

    Mombasa, Kenya

  • Mvita

    Mombasa, Kenya

  • Mwakirunge

    Mombasa, Kenya

  • Mwangaza

    Mombasa, Kenya

  • Pandya

    Mombasa, Kenya

  • Roadside

    Mombasa, Kenya

  • Shikaadabu

    Mombasa, Kenya

  • Shukurani

    Mombasa, Kenya

  • Singawa

    Mombasa, Kenya

  • St. Thomas

    Mombasa, Kenya

  • Tudor

    Mombasa, Kenya

  • Waweni

    Mombasa, Kenya

  • Wema

    Mombasa, Kenya

  • Ziwa la Ngombe

    Mombasa, Kenya

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Jun 2018
Primary completion
31 Dec 2019
Completion
31 Dec 2022
Last update posted
30 Nov 2023
Registered enrollment
24
Registry id
NCT02994355

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.